Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphomas cell lines BC-1 and BC-2

Virology

Volumn 264, Issue 2, 1999, Pages 359-369

  Aguirre, Andrew J ^a   Robertson, Erle S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ARTICLE; DATA ANALYSIS; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNOBLOTTING; LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING; VIRUS TRANSFORMATION;

EID: 0033604514     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0015     Document Type: Article

References (47)

1. Adldinger H. K., Delius H., Freese U. K., Clarke J., Bornkamm G. W. A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology. 141:1985;221-234.
2. Alsip G. R., Ench Y., Sumaya C. V., Boswell R. N. Increased Epstein-Barr virus DNA in oropharyngeal secretions from patients with AIDS, AIDS-related complex, or asymptomatic human immunodeficiency virus infections. J Infect. Dis. 157:1988;1072-1076.
3. Arrand J. R., Young L. S., Tugwood J. D. Two families of sequences in the small RNA-encoding region of Epstein- Barr virus (EBV) correlate with EBV types A and B. J. Virol. 63:1989;983-986.
4. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C., Seguin C. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 310:1984;207-211.
5. Bouzid M., Belkaid M. I., Colonna P., Bouguermouh A. M., Ooka T. Co-existence of the A and B types of Epstein-Barr virus DNA in lymph node biopsies from Algerian patients with Hodgkin's disease and non-Hodgkin's lymphoma. Leukemia. 7:1993;1451-1455.
6. Buisson M., Morand P., Genoulaz O., Bourgeat M. J., Micoud M., Seigneurin J. M. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. J. Gen. Virol. 75:1994;431-437.
7. Burrows J. M., Khanna R., Sculley T. B., Alpers M. P., Moss D. J., Burrows S. R. Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J. Virol. 70:1996;4829-4833.
8. Cesarman E., Moore P. S., Rao P. H., Inghirami G., Knowles D. M., Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 86:1995;2708-2714.
9. Cohen J. I., Wang F., Kieff E. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation. J. Virol. 65:1991;2545-2554.
10. Dambaugh T., Hennessy K., Chamnankit L., Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc. Natl. Acad. Sci. USA. 81:1984;7632-7636.
11. Gratama J. W., Oosterveer M. A., Weimar W., Sintnicolaas K., Sizoo W., Bolhuis R. L., Ernberg I. Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J. Gen. Virol. 75:1994;85-94.
12. Heller M., Dambaugh T., Kieff E. Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells. J. Virol. 38:1981;632-648.
13. Horenstein M. G., Nador R. G., Chadburn A., Hyjek E. M., Inghirami G., Knowles D. M., Cesarman E. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood. 90:1997;1186-1191.
14. Izumi K. M., Kaye K. M., Kieff E. D. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA. 94:1997;1447-1452.
15. Katz B. Z., Andiman W. A., Eastman R., Martin K., Miller G. Infection with two genotypes of Epstein-Barr virus in an infant with AIDS and lymphoma of the central nervous system. J. Infect. Dis. 153:1986;601-604.
16. Kaye K. M., Izumi K. M., Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B- lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA. 90:1993;9150-9154.
17. Kieff E. Epstein-Barr Virus and Its Replication. Fields K. D., Howley B. P. Fields Virology. 1996;Lippincott-Raven, Philadelphia.
18. Mannick J. B., Cohen J. I., Birkenbach M., Marchini A., Kieff E. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:1991;6826-6837.
19. Miller G., Robinson J., Heston L., Lipman M. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference. Proc. Natl. Acad. Sci. USA. 71:1974;4006-4010.
20. Miller G., Shope T., Lisco H., Stitt D., Lipman M. Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes. Proc. Natl. Acad. Sci. USA. 69:1972;383-387.
21. Rabson M., Gradoville L., Heston L., Miller G. Non-immortalizing P3J-HR-1 Epstein-Barr virus: A deletion mutant of its transforming parent, Jijoye. J. Virol. 44:1982;834-844.
22. Rickinson A. a. E. K. Epstein-Barr Virus. Fields K. D., Howley B. P. Fields Virology. 1996;Lippincott-Raven, Philadelphia.
23. Rickinson A. B., Young L. S., Rowe M. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 61:1987;1310-1317.
24. Robertson E., Kieff E. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. J. Virol. 69:1995;983-993.
25. Robertson E. S., Tomkinson B., Kieff E. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro. J. Virol. 68:1994;1449-1458.
26. Rooney C., Howe J. G., Speck S. H., Miller G. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. J. Virol. 63:1989;1531-1539.
27. Rowe D. T., Clarke J. R. The type-specific epitopes of the Epstein-Barr virus nuclear antigen 2 are near the carboxy terminus of the protein. J. Gen. Virol. 70:1989;1217-1229.
28. Rowe M., Young L. S., Cadwallader K., Petti L., Kieff E., Rickinson A. B. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. J. Virol. 63:1989;1031-1039.
29. Sample J., Brooks L., Sample C., Young L., Rowe M., Gregory C., Rickinson A., Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl. Acad. Sci. USA. 88:1991;6343-6347.
30. Sample J., Young L., Martin B., Chatman T., Kieff E., Rickinson A. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J. Virol. 64:1990;4084-4092.
31. Sculley T. B., Apolloni A., Hurren L., Moss D. J., Cooper D. A. Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J. Infect. Dis. 162:1990;643-648.
32. Sculley T. B., Apolloni A., Stumm R., Moss D. J., Mueller-Lantczh N., Misko I. S., Cooper D. A. Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus. Virology. 171:1989;401-408.
33. Skare J., Farley J., Strominger J. L., Fresen K. O., Cho M. S., zur Hausen H. Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H. J. Virol. 55:1985;286-297.
34. Strauch B., Andrews L. L., Siegel N., Miller G. Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet. 1:1974;234-237.
35. Szekely L., Chen F., Teramoto N., Ehlin-Henriksson B., Pokrovskaja K., Szeles A., Manneborg-Sandlund A., Lowbeer M., Lennette E. T., Klein G. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line [published erratum appears in J Gen Virol 1998 Nov;79(Pt 11):2875]. J. Gen. Virol. 79:1998;1445-1452.
36. Tomkinson B., Kieff E. Second-site homologous recombination in Epstein-Barr virus: Insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection. J. Virol. 66:1992a;780-789.
37. Tomkinson B., Kieff E. Use of second-site homologous recombination to demonstrate that Epstein- Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J. Virol. 66:1992b;2893-2903.
38. Tomkinson B., Robertson E., Kieff E. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:1993a;2014-2025.
39. Tomkinson B., Robertson E., Yalamanchili R., Longnecker R., Kieff E. Epstein-Barr virus recombinants from overlapping cosmid fragments. J. Virol. 67:1993b;7298-7306.
40. Walling D. M., Clark N. M., Markovitz D. M., Frank T. S., Braun D. K., Eisenberg E., Krutchkoff D. J., Felix D. H., Raab-Traub N. Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia [see comments]. J. Infect. Dis. 171:1995;1122-1130.
41. Walling D. M., Edmiston S. N., Sixbey J. W., Abdel-Hamid M., Resnick L., Raab-Traub N. Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc. Natl. Acad. Sci. USA. 89:1992;6560-6564.
42. Walling D. M., Perkins A. G., Webster-Cyriaque J., Resnick L., Raab-Traub N. The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: Strain variation, genetic recombination, and transcriptional expression. J. Virol. 68:1994;7918-7926.
43. Walling D. M., Raab-Traub N. Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J. Virol. 68:1994;7909-7917.
44. Yao Q. Y., Croom-Carter D. S., Tierney R. J., Habeshaw G., Wilde J. T., Hill F. G., Conlon C., Rickinson A. B. Epidemiology of infection with Epstein-Barr virus types 1 and 2: Lessons from the study of a T-cell-immunocompromised hemophilic cohort. J. Virol. 72:1998;4352-4363.
45. Yao Q. Y., Rowe M., Martin B., Young L. S., Rickinson A. B. The Epstein-Barr virus carrier state: Dominance of a single growth- transforming isolate in the blood and in the oropharynx of healthy virus carriers. J. Gen. Virol. 72:1991;1579-1590.
46. Yao Q. Y., Tierney R. J., Croom-Carter D., Cooper G. M., Ellis C. J., Rowe M., Rickinson A. B. Isolation of intertypic recombinants of Epstein-Barr virus from T-cell- immunocompromised individuals. J. Virol. 70:1996a;4895-4903.
47. Yao Q. Y., Tierney R. J., Croom-Carter D., Dukers D., Cooper G. M., Ellis C. J., Rowe M., Rickinson A. B. Frequency of multiple Epstein-Barr virus infections in T-cell- immunocompromised individuals. J. Virol. 70:1996b;4884-4894.